qq: It depends upon the acquiring company's cash position. Novartis (Yahoo) says it has $18.73B in cash. More than enough to acquire us using cash. But, if they needed their cash for expansion and marketing, then @ $83 per share they could issue 73 million shares (approx. $6B) a virtual drop (not really) in the bucket to their outstanding 2.12Bshares. A 3.4% dilution. I can definitely see your point. However.....
Novartis would then be in the drivers seat in the Cardiovascular arena.
If it were me I'd accept cash and shares and call it good. Novartis pays a 4% dividend. I'd be a happy clam for sure.
BTW, $6B gets us approx. a $15 buyout price, within my range for sure.
News 
Market Data 
Discover 
